These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37068440)

  • 1. Therapeutic potential of oxo-triarylmethyl (oxTAM) as a targeted drug delivery system for nitrosourea and fluorouracil anticancer drugs; A first principles insight.
    Asif M; Sajid H; Ayub K; Gilani MA; Anwar N; Mahmood T
    J Mol Graph Model; 2023 Jul; 122():108469. PubMed ID: 37068440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent Organic Framework (C
    Alkhalifah MA; Yar M; Bayach I; Sheikh NS; Ayub K
    Materials (Basel); 2022 Oct; 15(21):. PubMed ID: 36363017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface adsorption of nitrosourea on pristine and doped (Al, Ga and In) boron nitride nanosheets as anticancer drug carriers: the DFT and COSMO insights.
    Ema SN; Khaleque MA; Ghosh A; Piya AA; Habiba U; Shamim SUD
    RSC Adv; 2021 Nov; 11(58):36866-36883. PubMed ID: 35494400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells.
    Mansoori B; Mohammadi A; Abedi-Gaballu F; Abbaspour S; Ghasabi M; Yekta R; Shirjang S; Dehghan G; Hamblin MR; Baradaran B
    J Cell Physiol; 2020 Oct; 235(10):6817-6830. PubMed ID: 31989649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier.
    Li M; Liang Z; Sun X; Gong T; Zhang Z
    PLoS One; 2014; 9(11):e112888. PubMed ID: 25389968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating the Drug Release from Metal-Organic Framework Nanocomposites via In Situ Synchrotron Microspectroscopy and Theoretical Modeling.
    Souza BE; Donà L; Titov K; Bruzzese P; Zeng Z; Zhang Y; Babal AS; Möslein AF; Frogley MD; Wolna M; Cinque G; Civalleri B; Tan JC
    ACS Appl Mater Interfaces; 2020 Jan; 12(4):5147-5156. PubMed ID: 31904920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan/carbon quantum dot/aptamer complex as a potential anticancer drug delivery system towards the release of 5-fluorouracil.
    Zavareh HS; Pourmadadi M; Moradi A; Yazdian F; Omidi M
    Int J Biol Macromol; 2020 Dec; 165(Pt A):1422-1430. PubMed ID: 32987067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core-shell structured 5-FU@ZIF-90@ZnO as a biodegradable nanoplatform for synergistic cancer therapy.
    Xiao X; Liang S; Zhao Y; Huang D; Xing B; Cheng Z; Lin J
    Nanoscale; 2020 Feb; 12(6):3846-3854. PubMed ID: 31995084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(amidoamine) Dendrimers as Nanocarriers for 5-Fluorouracil: Effectiveness of Complex Formation and Cytotoxicity Studies.
    Szota M; Reczyńska-Kolman K; Pamuła E; Michel O; Kulbacka J; Jachimska B
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and efficiency of a methyl-carboxylated 5-Fluorouracil-bovine serum albumin adduct for targeted delivery.
    Koziol MJ; Sievers TK; Smuda K; Xiong Y; Müller A; Wojcik F; Steffen A; Dathe M; Georgieva R; Bäumler H
    Macromol Biosci; 2014 Mar; 14(3):428-39. PubMed ID: 24821671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy.
    Valencia-Lazcano AA; Hassan D; Pourmadadi M; Shamsabadipour A; Behzadmehr R; Rahdar A; Medina DI; Díez-Pascual AM
    Eur J Med Chem; 2023 Jan; 246():114995. PubMed ID: 36493619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zeolitic Imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle.
    Sun CY; Qin C; Wang XL; Yang GS; Shao KZ; Lan YQ; Su ZM; Huang P; Wang CG; Wang EB
    Dalton Trans; 2012 Jun; 41(23):6906-9. PubMed ID: 22580798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells.
    Sharma A; Kaur A; Jain UK; Chandra R; Madan J
    Colloids Surf B Biointerfaces; 2017 Jul; 155():200-208. PubMed ID: 28431329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
    Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexagonal boron nitride nanosheet as novel drug delivery system for anticancer drugs: Insights from DFT calculations and molecular dynamics simulations.
    Vatanparast M; Shariatinia Z
    J Mol Graph Model; 2019 Jun; 89():50-59. PubMed ID: 30870649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical study of gallium nitride nanocage as a carrier for 5-fluorouracil anticancer drug.
    Wazzan N; Soliman KA; Halim WSA
    J Mol Model; 2019 Aug; 25(9):265. PubMed ID: 31444705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Watson-Crick G[triple bond, length as m-dash]C"-inspired supramolecular nanodrug of methotrexate and 5-fluorouracil for tumor microenvironment-activatable self-recognizing synergistic chemotherapy.
    Chen M; Chen S; Zhu F; Wang F; Tian H; Fan Z; Ke S; Hou Z; Li Y
    J Mater Chem B; 2020 May; 8(17):3829-3841. PubMed ID: 32232285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical Investigation of Chitosan-Assisted Controlled Release of Digestive System Antitumor Drug Fluorouracil.
    Lu Y; Liang L; Shen G; Yao W; Zhang C; Huang D; Xuan Z; Li J; Liu J
    J Pharm Sci; 2022 Jul; 111(7):2049-2055. PubMed ID: 35122829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photo-triggered release of 5-fluorouracil from a MOF drug delivery vehicle.
    Roth Stefaniak K; Epley CC; Novak JJ; McAndrew ML; Cornell HD; Zhu J; McDaniel DK; Davis JL; Allen IC; Morris AJ; Grove TZ
    Chem Commun (Camb); 2018 Jul; 54(55):7617-7620. PubMed ID: 29926872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
    Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
    Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.